LZRS-Rfa Citations (4)
Originally described in: Mek1 alters epidermal growth and differentiationScholl FA, Dumesic PA, Khavari PA Cancer Res. 2004 Sep 1;64(17):6035-40 PubMed Journal
Articles Citing LZRS-Rfa
Articles |
---|
The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells. Heubach J, Monsior J, Deenen R, Niegisch G, Szarvas T, Niedworok C, Schulz WA, Hoffmann MJ. Mol Cancer. 2015 May 21;14:108. doi: 10.1186/s12943-015-0371-8. PubMed |
Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity. Ghosh A, Smith M, James SE, Davila ML, Velardi E, Argyropoulos KV, Gunset G, Perna F, Kreines FM, Levy ER, Lieberman S, Jay HV, Tuckett AZ, Zakrzewski JL, Tan L, Young LF, Takvorian K, Dudakov JA, Jenq RR, Hanash AM, Motta AC, Murphy GF, Liu C, Schietinger A, Sadelain M, van den Brink MR. Nat Med. 2017 Jan 9. doi: 10.1038/nm.4258. PubMed |
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells. Patel H, Mishra R, Wier A, Mokhtarpour N, Merino EJ, Garrett JT. Anticancer Drugs. 2023 Apr 1;34(4):519-531. doi: 10.1097/CAD.0000000000001500. Epub 2023 Feb 10. PubMed |
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation. Barakat C, Inagaki Y, Mizuno S, Nishio N, Katsuyama N, Sato Y, Kobayashi M, Ozeki K, Iida H, Tomita A, Sawa M, Demachi-Okamura A, Takahashi Y, Nishikawa H, Akatsuka Y. Int J Hematol. 2023 Aug;118(2):252-266. doi: 10.1007/s12185-023-03621-y. Epub 2023 Jun 13. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.